Roger L. Papke

An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype

Roger L. Papke, Merouane Bencherif, Patrick M. Lippiello · Neuroscience Letters · 1996 · 274 citations

Molecular Pharmacology, Quaternary Nitrogen Compounds, Neurophysiology +12

Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor Subtypes

Roger L. Papke, Paul R. Sanberg, R. Douglas Shytle · Journal of Pharmacology and Experimental Therapeutics · 2001 · 267 citations

Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.

Roger L. Papke, Steve Heinemann · Molecular Pharmacology · 1994 · 259 citations

Comparative pharmacology of rat and human α7 nAChR conducted with net charge analysis

Roger L. Papke, Julia Kay Porter Papke · British Journal of Pharmacology · 2002 · 247 citations · Full text

Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.

Christopher M. de Fiebre, Éric Meyer, J C Henry et al. · Molecular Pharmacology · 1995 · 195 citations